Glipizide
NDC 51655-966, Glipizide, tablet, film coated, extended release, from Northwind Health Company, LLC.
- Product NDC
- 51655-966
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204720
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51655-966 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLIPIZIDE10 mg/1
Pharmacologic classes
Sulfonylurea Compounds [CS]; Sulfonylurea [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51655-966-26 | 51655096626 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-966-26) |
| 51655-966-52 | 51655096652 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-966-52) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/ff9b3b7a-5ab1-45ec-e053-6294a90af426
Use it
Look up 51655-966 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51655-966 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51655-966. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.